ELISA Negative but qPCR Detected: Technical Interpretation of Conflicting Results in Food Laboratories

Conflicting analytical results between immunoassays (ELISA) and molecular assays (qPCR) are not uncommon in food testing laboratories.

A frequent scenario observed during routine monitoring is:

• ELISA: Negative

• qPCR: Detected

Such outcomes often raise concerns regarding method reliability, contamination events, or laboratory error. However, in most cases, the discrepancy reflects fundamental biological and analytical differences between the two techniques.

A technically sound interpretation requires understanding what each method measures, how processing affects targets, and how detection limits influence reporting.

Fundamental Analytical Differences Between ELISA and qPCR

ELISA (Enzyme-Linked Immunosorbent Assay) detects specific proteins or antigens using antibody-antigen interactions.

qPCR (quantitative Polymerase Chain Reaction) detects and amplifies specific DNA sequences.

This distinction is critical.

Parameter	ELISA	qPCR
Target	Protein	DNA
Sensitivity	Moderate	High
Detects viable organisms?	Generally yes (intact proteins)	Not necessarily
Affected by protein denaturation?	Yes	No
Affected by DNA degradation?	No	Yes

Because DNA and proteins degrade differently under environmental and processing stresses, discordant results are biologically plausible.

ELISA detects proteins, while qPCR detects DNA—differences that can lead to conflicting results in food testing.

Mechanism 1: DNA Persistence After Protein Denaturation

Thermal processing, pasteurization, drying, or chemical sanitizers may:

• Denature proteins beyond antibody recognition

• Fragment or reduce antigenicity

• Leave small DNA fragments intact

In dairy systems, for example, high-temperature short-time (HTST) processing may disrupt surface proteins while DNA remains amplifiable.

qPCR assays targeting short amplicons (e.g., 80–150 bp) can still generate amplification signals from fragmented DNA.

In such cases:

ELISA → Negative (no intact antigen)qPCR → Detected (residual DNA present)

This does not necessarily indicate viable contamination.

Mechanism 2: Analytical Sensitivity Differences

qPCR typically has lower limits of detection compared to ELISA.

Low-level contamination scenarios may produce:

• Ct values near assay detection threshold

• Amplification curves consistent with trace DNA presence

However, antigen concentration may remain below ELISA detection capability.

This is particularly relevant in:

• Environmental monitoring swabs

• Post-cleaning verification

• Low-biomass finished products

Mechanism 3: Matrix-Dependent Interference

Food matrices influence assay performance differently.

In milk and dairy systems:

• Fat globules may interfere with antigen extraction in ELISA

• Calcium and inhibitors may impact DNA extraction efficiency

In spices or dry powders:

• Polyphenols may inhibit PCR if extraction is inadequate

• Protein denaturation may reduce ELISA binding efficiency

Therefore, matrix validation data must always be reviewed before interpreting ELISA negative qPCR detected results.

Role of Ct Value Interpretation

When qPCR reports “Detected,” technical review must include:

• Ct value magnitude

• Amplification curve morphology

• Replicate consistency

• Positive and negative control performance

High Ct values (e.g., >35 depending on assay design) often indicate low-level DNA presence.

Laboratories should determine whether their validation studies established:

• Limit of detection (LOD)

• Limit of quantification (LOQ)

• Reporting thresholds

• Action limits

Without predefined interpretation criteria, conflicting results can be mismanaged.

Viability Considerations

qPCR does not inherently differentiate between:

• Viable organisms

• Non-viable organisms

• Free DNA fragments

If product risk depends on viable pathogen presence, additional tools may be required:

• Culture confirmation

• PMA-qPCR (propidium monoazide treatment)

• Enrichment prior to molecular detection

Decision-making should reflect product type, process lethality, and regulatory expectations.

Risk-Based Interpretation Framework for ELISA Negative qPCR Detected Results

When such results occur, laboratories should systematically evaluate:

1. Processing history (thermal, chemical, drying)

2. Matrix validation data

3. Ct values and amplification quality

4. Historical trend data

5. Defined action limits

6. Intended product use and consumer risk

Escalation decisions should not be based solely on method discrepancy.

They should be based on biological plausibility and documented criteria.

Audit Perspective

During audits, inspectors typically assess:

• Whether method differences are understood

• Whether conflicting results are documented with rationale

• Whether decision trees are predefined

• Whether validation supports interpretation

A laboratory that documents structured reasoning demonstrates control.

A laboratory that reacts without analysis demonstrates weakness.

Conclusion

ELISA negative qPCR detected outcomes are not analytical contradictions.

They reflect:

• Different biological targets

• Different sensitivities

• Different stability profiles

• Different matrix interactions

Understanding these technical principles allows laboratories to move from reactive interpretation to structured molecular maturity.

Conflicting results should trigger investigation — not assumption.

Supporting Structured Molecular Interpretation

As molecular testing becomes more sensitive, interpretation frameworks must evolve alongside it.

At 2F Quality Solutions, we support food manufacturers and in-house laboratories in strengthening molecular validation, defining action limits, and building audit-ready interpretation systems.

The goal is simple: improve decision clarity and ensure that molecular results translate into defensible, risk-based actions.